Home

ANTON GUETH

CIK 1274940 · last filed 2022-05-26

ANTON GUETH is a corporate insider who has filed 34 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.84M

Companies

4

Total Filings

34

Lifetime Open-Market Net

-$1.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANTARES PHARMA, INC. (ATRS) Delisted Director 467,577 $5.59 $2.61M -$808.0K 18 2021-07-09
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Director 38,918 $0.00 $4 $0 2 2016-01-08
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Director 11,000 $1.03 $11.3K $0 2 2012-12-21
AIS Director 141,101 $76.82 $10.84M -$237.6K 11 2012-05-31

Recent Filings

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-26 — Disp (D) −467,577 -$2.62M
2021-07-09 ANTARES PHARMA, INC. (ATRS) Delisted Sell (S) −100,000 -$429.0K EDGAR
2021-06-14 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) +25,452 $112.5K EDGAR
2021-05-06 ANTARES PHARMA, INC. (ATRS) Delisted Exer (M) +40,000 $66.4K EDGAR
2021-05-03 ANTARES PHARMA, INC. (ATRS) Delisted Exer (M) +72,669 $120.6K EDGAR
2020-06-15 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) +30,220 $82.5K EDGAR
2020-05-15 ANTARES PHARMA, INC. (ATRS) Delisted Exer (M) +72,487 $116.0K EDGAR
2019-06-14 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) +23,973 $70.0K EDGAR
2018-06-11 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) — $0 EDGAR
2017-06-09 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.